The prevalence of neural tube defects has dipped significantly during the past thirty years due to advances in ultrasonography's refined resolution for in utero fetal examination, theÂ clinical availability of laboratory markers like serum alpha-fetoprotein measurements, termination of affected pregnancies, and consumption of folic acid supplements by women in the reproductive age group.

Mothers with diabetes, obesity, hyperthermia, drugs that interfere with folate metabolisms, excessive vitamin A, cigarette smoking, alcohol consumption during pregnancy, and antiepileptic drugs like valproate and carbamazepine have increased risk of children with Neural tube defects. Folic acid supplementation of 4 mg to mothers with risk factors. Prenatal screening for neurological abnormalities is based on an ultrasound performed routinely or oriented by maternal alpha-fetoprotein (AFP) screening around 12, 22, and 32 weeks.